Skip to content

Clinical trials

Phase 2 Lymphoma, Large B-Cell, Diffuse trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 2 Country / region: Canada Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20021
20051
20073
20101
20111
20121
20131
20141
20153
20172
20181
20192
20212
20221
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting5
Terminated5
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ImmunoVaccine Technologies, Inc. (IMV Inc.)2
Novartis Pharmaceuticals2
Alliance for Clinical Trials in Oncology1
Allogene Therapeutics1
Astellas Pharma Inc1
Bayer1
CTI BioPharma1
Calithera Biosciences, Inc1
Celgene Corporation1
Children's Oncology Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse29
Lymphoma13
Lymphoma, Non-Hodgkin12
Lymphoma, B-Cell7
Lymphoma, Follicular6
Recurrence6
Burkitt Lymphoma5
Lymphoma, Large-Cell, Immunoblastic5
Lymphoma, Mantle-Cell5
Precursor Cell Lymphoblastic Leukemia-Lymphoma3

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.